These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22503667)

  • 1. Mini-invasive videoassisted thyroid lobectomy for neonatal hyperfunctioning adenoma related to a somatic TSHr gene mutation.
    Stocco E; Pelizzo MR; Grassetto G; Pagetta C; Larizza D; Massaro A; Marzola MC; Rubello D
    Ann Endocrinol (Paris); 2012 Jun; 73(3):230-2. PubMed ID: 22503667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas.
    Nanba K; Usui T; Minamiguchi S; Mori Y; Watanabe Y; Honda K; Asato R; Nakao K; Kawashima ST; Yuno A; Tamanaha T; Tagami T; Naruse M; Akiyama Y; Shimatsu A
    Endocr J; 2012; 59(1):13-9. PubMed ID: 22001338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy.
    Kraemer S; Rothe K; Pfaeffle R; Fuehrer-Sakel D; Till H; Muensterer OJ
    J Pediatr Endocrinol Metab; 2009 Mar; 22(3):269-74. PubMed ID: 19492584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkitt-like lymphoma infiltrating a hyperfunctioning thyroid adenoma and presenting as a hot nodule.
    Camera A; Magri F; Fonte R; Villani L; Della Porta MG; Fregoni V; Manna LL; Chiovato L
    Thyroid; 2010 Sep; 20(9):1033-6. PubMed ID: 20825299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
    Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
    Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
    Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.
    Kopp P; Muirhead S; Jourdain N; Gu WX; Jameson JL; Rodd C
    J Clin Invest; 1997 Sep; 100(6):1634-9. PubMed ID: 9294132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activating mutations of the TSH receptor: a synthesis highlighting certain pediatric aspects].
    Polak M
    Arch Pediatr; 1998; 5 Suppl 4():375S-379S. PubMed ID: 9853087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene.
    Tonacchera M; Agretti P; Rosellini V; Ceccarini G; Perri A; Zampolli M; Longhi R; Larizza D; Pinchera A; Vitti P; Chiovato L
    Thyroid; 2000 Oct; 10(10):859-63. PubMed ID: 11081252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solitary hyperfunctioning thyroid adenoma in a child. Elevated T3 and T4 levels with normal TSH level.
    Taylor HC
    JAMA; 1975 Dec; 234(12):1253-5. PubMed ID: 1242753
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.
    Hébrant A; van Staveren WC; Maenhaut C; Dumont JE; Leclère J
    Eur J Endocrinol; 2011 Jan; 164(1):1-9. PubMed ID: 20926595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary culture of cells from hyperfunctioning thyroid adenoma with an activating mutation of G alphas.
    Kamiya Y; Murakami M; Yanagita Y; Koitabashi H; Nagamachi Y; Hosoi Y; Ogiwara T; Mizuma H; Iriuchijima T; Mori M
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):137-42. PubMed ID: 9685222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A somatic gain-of-function mutation in the thyrotropin receptor gene producing a toxic adenoma in an infant.
    Kohn B; Grasberger H; Lam LL; Ferrara AM; Refetoff S
    Thyroid; 2009 Feb; 19(2):187-91. PubMed ID: 19191749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.
    Tonacchera M; Agretti P; Chiovato L; Rosellini V; Ceccarini G; Perri A; Viacava P; Naccarato AG; Miccoli P; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2270-4. PubMed ID: 10852462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of thyrotropin receptor residue Asp403 in a hyperfunctioning thyroid nodule provides insight into the role of the ectodomain in ligand-induced receptor activation.
    Nishihara E; Chen CR; Mizutori-Sasai Y; Ito M; Kubota S; Amino N; Miyauchi A; Rapoport B
    J Endocrinol Invest; 2012 Jan; 35(1):49-53. PubMed ID: 21597314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
    Castro I; Lima L; Seoane R; Lado-Abeal J
    Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coincidental thyroid papillary microcarcinoma in a patient treated for a toxic adenoma of the thyroid.
    Polyzos SA; Goulis DG
    Arch Iran Med; 2011 Mar; 14(2):149-51. PubMed ID: 21361725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.